dapsone has been researched along with Disease Exacerbation in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present two cases of patients diagnosed with lupus nephritis (LN) who demonstrated persistent proteinuria while on standard treatments that markedly improved after addition of thalidomide (THD)." | 8.95 | Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis. ( Carter, JD; Patel, AA; Raturi, R, 2017) |
| " We present two cases of patients diagnosed with lupus nephritis (LN) who demonstrated persistent proteinuria while on standard treatments that markedly improved after addition of thalidomide (THD)." | 4.95 | Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis. ( Carter, JD; Patel, AA; Raturi, R, 2017) |
| "Haemorrhagic bullous lesions are a recognized but rare occurrence with HSP in children." | 2.45 | Management of haemorrhagic bullous lesions in Henoch-Schonlein purpura: is there any consensus? ( Kausar, S; Yalamanchili, A, 2009) |
| "Lepromatous leprosy is associated with a high bacillary load and poor cellular immune response." | 1.56 | Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment. ( Bidari-Zerehpoosh, F; Bizaval, Z; Mozafari, N; Niknejad, N; Robati, RM, 2020) |
| "Dapsone was the most commonly used drug (51 patients), followed by methotrexate (24 patients), azathioprine (23 patients), and cyclophosphamide (15 patients); prednisone, always given as adjunctive treatment, was used in 17 patients." | 1.31 | The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. ( Ahmed, AR; Baltatzis, S; Foster, CS; Miserocchi, E; Roque, MR, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Robati, RM | 1 |
| Mozafari, N | 1 |
| Bidari-Zerehpoosh, F | 1 |
| Niknejad, N | 1 |
| Bizaval, Z | 1 |
| Fischer, M | 1 |
| Tate, C | 1 |
| Christian, W | 1 |
| Newell, L | 1 |
| Justice, JM | 1 |
| Solyar, AY | 1 |
| Davis, KM | 1 |
| Lanza, DC | 1 |
| Raturi, R | 1 |
| Patel, AA | 1 |
| Carter, JD | 1 |
| Kausar, S | 1 |
| Yalamanchili, A | 1 |
| Desenfants, A | 1 |
| Huguon, E | 1 |
| Polfrit, Y | 1 |
| Crouzat, M | 1 |
| Rouleau, V | 1 |
| Chassot, V | 1 |
| Besson-Leaud, L | 1 |
| Missotte, I | 1 |
| Goulart, IM | 1 |
| Reis, AC | 1 |
| De Rezende, TM | 1 |
| Borges, AS | 1 |
| Ferreira, MS | 1 |
| Nishioka, SA | 1 |
| Chawla, S | 1 |
| Smart, CJ | 1 |
| Moots, RJ | 1 |
| Kanda, Y | 1 |
| Chiba, S | 1 |
| Hirano, N | 1 |
| Hirai, H | 1 |
| Yazaki, Y | 1 |
| Manuelidis, L | 1 |
| Fritch, W | 1 |
| Zaitsev, I | 1 |
| Peterson, CM | 1 |
| Ahkavan, M | 1 |
| Fernandez-Soto, ML | 1 |
| Rowell, C | 1 |
| Scott, BK | 1 |
| Peterson, KP | 1 |
| Miserocchi, E | 1 |
| Baltatzis, S | 1 |
| Roque, MR | 1 |
| Ahmed, AR | 1 |
| Foster, CS | 1 |
4 reviews available for dapsone and Disease Exacerbation
| Article | Year |
|---|---|
Leprosy - an overview of clinical features, diagnosis, and treatment.
Topics: Adult; Aged; Child; Clofazimine; Cross-Sectional Studies; Dapsone; Disease Progression; Drug Adminis | 2017 |
Progressive left nasal obstruction and intermittent epistaxis.
Topics: Animals; Biopsy, Needle; Combined Modality Therapy; Dapsone; Disease Progression; Epistaxis; Follow- | 2013 |
Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis.
Topics: Adolescent; Adult; Dapsone; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosu | 2017 |
Management of haemorrhagic bullous lesions in Henoch-Schonlein purpura: is there any consensus?
Topics: Adrenal Cortex Hormones; Blister; Child; Combined Modality Therapy; Dapsone; Disease Progression; Dr | 2009 |
9 other studies available for dapsone and Disease Exacerbation
| Article | Year |
|---|---|
Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Topics: Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combination; Erythema Nodosum; Humans; Lepr | 2020 |
Chronic Bullous Dermatosis of Childhood and the String of Pearls Sign.
Topics: Biopsy, Needle; Child, Preschool; Cyclosporine; Dapsone; Diagnosis, Differential; Disease Progressio | 2018 |
[Leprosy with an unusual course].
Topics: Anemia, Hemolytic; Child; Dapsone; Disease Progression; Drug Therapy, Combination; Erythema Nodosum; | 2012 |
Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Topics: Adult; Anemia, Aplastic; Brazil; Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combinatio | 2005 |
Recto-vaginal fistula: a refractory complication of Behcet's disease.
Topics: Adult; Antibodies, Monoclonal; Behcet Syndrome; Dapsone; Disease Progression; Female; Humans; Inflam | 2007 |
Rapid progression of chronic myelomonocytic leukemia following diaminodiphenyl sulphone treatment for dermatitis herpetiformis.
Topics: Adult; Dapsone; Dermatitis Herpetiformis; Disease Progression; Humans; Leprostatic Agents; Leukemia, | 1997 |
Dapsone to delay symptoms in Creutzfeldt-Jakob disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Creutzfeldt-Jakob Syndrome; Dapsone; Disease Progr | 1998 |
Dapsone at onset of diabetes lowers glycated hemoglobin and delays death in NOD mice.
Topics: Age of Onset; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Dapsone; | 1998 |
The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathi | 2002 |